Pfizer, Flynn Pharma Find New UK Competition Fine No Better
Pfizer and Flynn Pharma are unhappy with the recently reevaluated £70 million ($81 million) fine doled out by Britain's competition regulator after they won an appeal of the original £89 million assessment, so...To view the full article, register now.
Already a subscriber? Click here to view full article